Three major projects, focusing on reducing stigma, community-led models and assessment of people living with chronic hepatitis B, have received funding.
The third-generation vaccine has fewer potential side effects than second-generation vaccines and can be safely given to people with weakened immune systems.
Research estimates that in Australia a blood donation from a person who could potentially transmit Creutzfeldt–Jakob disease would occur once every 65 years.
